Preferences help
enabled [disable] Abstract
Number of results
2014 | 61 | 4 | 699-703
Article title

Phosphorylation sites of HER2/c-erbB-2: role in cell growth and in disease

Title variants
Languages of publication
The protein kinase c-erbB-2 belongs to the family of receptor tyrosine kinase and is involved in oncogenesis. The present study predicts different phosphorylation sites of HER2/c-erbB-2 which are important in preventing or developing cancer, especially breast cancer. Sequence homology showed highest homology (77%) with epidermal growth factor receptor kinase domain. According to PROSITE search result, active sites of c-erbB-2 are N-lobe (glycine rich phosphate binding loop). Catalytic loop with presumptive catalytically active of Asp108 is phosphorylated by tyrosine protein kinase. A-loop, activation loop, becomes phosphorylated and activates the substrate binding. The study strengthens our knowledge regarding HER2 signaling by the detection of uncharacterized signaling proteins, establishing phosphorylation of an activation loop and helps us to make assumptions about the role of such previously unidentified proteins. On the basis of importance of HER2 in breast cancer as well as in other diseases, this study provides fruitful information for designing new therapeutic strategies.
Physical description
  • Department of Biochemistry, Fatima Jinnah Medical College, Lahore, Pakistan
  • Institute of Biochemistry and Biotechnology, University of the Punjab, Lahore, Pakistan
  • Department of Biochemistry, Gujranwala Medical College, Gujranwala, Pakistan
  • Institute of Biochemistry and Biotechnology, University of the Punjab, Lahore, Pakistan
  • Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990) Basic local alignment search tool. J Mol Biol 215: 403-410.
  • Bairoch A, Apweiler R (1997) The SWISS-PROT protein sequence data bank and its supplement TrEMBL. Nucleic Acids Res 25: 31-36.
  • Baselga J (2006) Targeting tyrosine kinases in cancer: the second wave. Science 312: 1175-1178.
  • Bixby JL (2001) Ligands and signaling through receptor type tyrosine phosphatases. IUBMB Life 51: 157-163.
  • Bose R, Molina H, Patterson AS, Bitok JK, Periaswamy B, Bader JS, Pandey A, Cole PA (2006) Phosphoproteomic analysis of Her2/neu signaling and inhibition. Proc Natl Acad Sci 103: 9773-9778.
  • Bose R, Zhang X (2009) The ErbB kinase domain: Structural perspectives into kinase activation and inhibition. Exp Cell Res 315: 649-658.
  • Chang H, Riese DJ, Gilbert W, Stern DF, McMahan UJ (1997) Ligands for ErbB-family receptors encoded by a neuregulin-like gene. Nature 387: 509-512.
  • Cho HS, Mason K, Ramyar KX, Stanley AM, Gabelli SB, Denney DW Jr, Leahy DJ (2003) Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab. Nature 421: 756-760.
  • Gotoh N, Tojo A, Hino M, Yazaki Y, Shibuya M (1992) A highly conserved tyrosine residue at codon 845 within the kinase domain is not required for the transforming activity of human epidermal growth factor receptor. Biochem Biophys Res Commun 186: 768-774.
  • Hoffhines AJ, Jen CH, Leary JA, Moore KL (2009) Tyrosylprotein sulfotransferase-2 expression is required for sulfation of RNase 9 and Mfge8 in vivo. J Biol Chem 284: 3096-3105.
  • Hubbard SR (1999) Structural analysis of receptor tyrosine kinases. Prog Biophys Mol Biol 71: 343-358.
  • Hubbard SR, Till JH (2000) Protein tyrosine kinase structure and function. Ann Rev Biochem 69: 373-398.
  • Hunter T (1998) The Croonian Lecture 1997. The phosphorylation of proteins on tyrosine: its role in cell growth and disease. Philos Trans R Soc Lond B Biol Sci 353: 583-605.
  • Klapper LN, Kirschbaum MH, Sela M, Yarden Y (2000) Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors. Adv Cancer Res 77: 25-79.
  • Klingbeil CK, Gill GN (1999) A basic residue, Lys 782, composes part of the ATP-binding site on the epidermal growth factor receptor tyrosine kinase. Arch Biochem Biophys 363: 27-32.
  • Kosoy A, O'Connell MJ (2008) Regulation of Chk1 by its C-terminal domain. Mol Biol Cell 19: 4546-4553.
  • Kulathu Y, Komander D (2012) Atypical ubiquitylation - the unexplored world of polyubiquitin beyond Lys48 and Lys63 linkages. Nat Rev Mol Cell Biol 13: 508-520.
  • Laskowski RA, McAurthur MW, Moss DS, Thornton JM (1993) PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Crystallogar 26: 283-291.
  • Lüftner D, Mazurek S, Henschke P, Mesterharm J, Schildhauer S, Geppert R, Wernecke KD, Possinger K (2003) Plasma levels of HER-2/neu, tumor type M2 pyruvate kinase and its tyrosine-phosphorylated metabolite in advanced breast cancer. Anticancer Res 23: 991-997.
  • Luo T, Lee Y, Saint-Jeannet J, Sargent TD (2003) Induction of neural crest in Xenopus by transcription factor AP2. PNAS 100: 532-537.
  • Malecka KA (2013) Something from nothing: The first phosphorylation. J Postdoc Res 1: 41-55.
  • Monteiro HP, Stern A (1996) Redox Modulation of tyrosine phosphorylation dependent signal transduction pathways. Free Radic Biol Med 21: 323-333.
  • Mukherji M, Brill LM, Ficarro SB, Hampton G, Schultz PG (2006) A phosphoproteomic analysis of the ErbB2 receptor tyrosine kinase signaling pathways. Biochemistry 45: 15529-15540.
  • Olayioye MA (2001) Update on HER-2 as a target for cancer therapy: Intracellular signaling pathways of ErbB2/HER-2 and family members. Breast Cancer Res 3: 385-389.
  • Radhakrishnan SS, Blalock TD, Robinson PM, Secker G, Daniels J, Grotendorst GR, Schultz GS (2012) Effect of connective tissue growth factor on protein kinase expression and activity in human corneal fibroblasts. Invest Ophthalmol Vis Sci 53: 8076-8085.
  • Ren K, Xian S, He F, Zhang W, Ding X, Wu Y, Yang L, Zhou J, Gao X, Zhang J (2011) CK2 phosphorylates AP-2α and increases its transcriptional activity. BMB Reports 44: 490-495.
  • Rodrigues CA, Park M (1994) Oncogenic activation of tyrosine kinases. Curr Opin Genet Dev 4: 15-24.
  • Romieu-Mourez R, Landesman-Bollag E, Seldin DC (2002) Protein kinase CK2 promotes aberrant activation of nuclear factor-kappaB, transformed phenotype, and survival of breast cancer cells. Cancer Res 62: 6770-6778.
  • Roskoski R (2005) Src kinase regulation by phosphorylation and dephosphorylation. Biochem Biophys Res Comm 331: 1-14.
  • Rowinsky EK (2004) The erbB Family: targets for therapeutic development against cancer and therapeutic strategies using monoclonal antibodies and tyrosine kinase inhibitors. Ann Rev Med 55: 433-457.
  • Sali A, Blundell TL (1993) Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 234: 779-815.
  • Schlessinger J, Lemmon MA (2003) SH2 and PTB domains in tyrosine kinase signaling. Sci STKE 191: RE12.
  • Schulze WX, Deng L, Mann M (2005) Phosphotyrosine interactome of the ErbB-receptor kinase family. Mol Syst Biol 1: 2005.0008.
  • Schaefer G, Akita RW, Sliwkowski MX (1999) A discrete three-amino acid segment (LVI) at the C-terminal end of kinase-impaired ErbB3 is required for transactivation of ErbB2. J Biol Chem 274: 859-866.
  • Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 177-182.
  • Stamos J, Sliwkowski MX, Eigenbrot C (2002) Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor. J Biol Chem 277: 46265-46272.
  • Sun H, Tonks NK (1994) The coordinated action of protein tyrosine phosphatase and kinases in cell signaling. Trends Biochem Sci 19: 480-485.
  • van Weeren PC, De Bruyn KM, De Vries-Smits AM, van Lint J, Burgering BM (1998) Essential role for protein kinase B (PKB) in insulin-induced glycogen synthase kinase 3 inactivation. Characterization of dominant-negative mutant of PKB. J Biol Chem 273: 13150-13160.
  • Vouzis PD, Sahinidis NV (2011) GPU-BLAST: using graphics processors to accelerate protein sequence alignment. Bioinformatics 27: 182-188.
  • Wolf-Yadlin A, Kumar N, Zhang Y, Hautaniemi S, Zaman M, Kim HD, Grantcharova V, Lauffenburger DA, White FM (2006) Effects of HER2 overexpression on cell signaling networks governing proliferation and migration. Mol Syst Biol 2: 54.
  • Wong LL, Chang CF, Koay ES, Zhang D (2009) Tyrosine phosphorylation of PP2A is regulated by HER-2 signalling and correlates with breast cancer progression. Int J Oncol 34: 1291-1301
Document Type
Publication order reference
YADDA identifier
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.